Findings

What do systematic reviews say?

6 questions · 6 findings · 3 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 16.7%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 1 · 16.7%Moderate 3 · 50%High 0 · 0%

Oral hydroxychloroquine vs placebo

Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus

Oral hydroxychloroquine showed no clear difference in adverse events: severe compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for cutaneous disease in systemic lupus erythematosus 2021 · Cochrane Headline outcomes only
RR 3.9 [0.19, 78.46]
1 study · 71 participants
Moderate

Oral dehydroepiandrosterone vs placebo

Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus

Oral dehydroepiandrosterone showed no clear difference in adverse events: severe compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for cutaneous disease in systemic lupus erythematosus 2021 · Cochrane Headline outcomes only
RR 0.09 [0.01, 1.66]
1 study · 381 participants
Moderate

Oral chloroquine vs placebo

Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus

Oral chloroquine showed no clear difference in adverse events: severe compared with placebo (low certainty).

1 finding from 1 review

Interventions for cutaneous disease in systemic lupus erythematosus 2021 · Cochrane Headline outcomes only
RR 0.33 [0.01, 7.45]
1 study · 24 participants
Low

Oral methotrexate vs placebo

Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus

Oral methotrexate showed no clear difference in adverse events: severe compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for cutaneous disease in systemic lupus erythematosus 2021 · Cochrane Headline outcomes only
RR 12.05 [0.69, 211.36]
1 study · 86 participants
Moderate

Rifampicin vs placebo

Proportion of participants with adverse events and severe adverse events · guttate psoriasis

The review found no eligible studies for this question.

1 finding from 1 review

Antistreptococcal interventions for guttate and chronic plaque psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Chemical peeling vs placebo or no treatment

Serious or severe adverse events N of participants with positive severe adverse events · people with acne scars

It is very uncertain whether chemical peeling changes serious or severe adverse events N of participants with positive… compared with placebo or no treatment (very low certainty).

1 finding from 1 review

Interventions for acne scars 2016 · Cochrane Headline outcomes only
RR 5.45 [0.33, 90.14]
1 study · 58 participants
Very low